ROG - Rogers Corporat Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (0.01%) BTCUSD (%) AQMS (0.67%) AMZA (0.21%) DOGEUSD (%) LTCUSD (%) NIO (-1.79%) TSIA (-0.28%) SNOW (-0.32%) SLB (-0.8%) ONTX (-0.97%) MWK (2.94%) MRNA (1.12%) BNBUSD (%) BHAT (-0.29%) GECC (0.41%) ETHUSD (%) DRI (0.38%) CNCE (0.96%) CLOV (-4.88%) CLDR (0.09%) CALA (1.96%) ALNA (-0.93%) ADMP (0.93%) ABT (0.08%)

Next Earnings Date : 4/29/2021

ROG - Rogers Corporation

$198.33 2.82[1.45%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$195.51	Open	$195.64
Volume	950	Market Cap	1.986B
Yield		Last Dividend

Day

52 Week

Roche confirms 2021 outlook as diagnosti...	6:20 AM
https://www.investing.com/news/stock-market-news/roche-confirms-2021-outlook-as-diagnostics-sales-mitigate-covid19-drug-slump-2480670

Roche Backs 2021 Outlook Despite Lacklus...	5:32 AM
Roche Holdings AG (OCTMKTS: RHHBY) posted Q1 sales of CHF 14.9 billion, up 3% Y/Y on a constant currency basis and down 1% on a reported basis. Sales ...

Roche trial for COVID-19 pill delayed in...	2:40 AM
https://www.investing.com/news/coronavirus/roche-trial-for-covid19-pill-delayed-in-uk-as-vaccine-rollout-intervened-2480476

Cipla doubles remdesivir production to m...	04/13/21
India's Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet "unprecedented demand" as the country battles a massive second...

ImagineAR (OTCQB:IPNFF) Selected by 13 S...	04/01/21
ImagineAR Selections Include Sinclair Broadcast Group, Rogers Sports & Media, Vegas Knights, Philadelphia Phillies, Minnesota Vikings VANCOUVER, BC an...

Alphabet, Baidu, NXP Semiconductors, Pin...	03/28/21
Cathie Wood???s Ark Investment Management sends out an email every night listing the stocks that were bought or sold by the firm's ETFs that day. In r...

Capital Square 1031 Acquires 280-Unit Mu...	03/24/21
CHESAPEAKE, Va. , March 24, 2021 /PRNewswire/ -- Capital Square 1031 , a leading sponsor of Delaware statutory trust (DST) offerings for 1031 exchange...

Pfizer begins early-stage study of oral ...	03/23/21
Pfizer Inc has started an early-stage U.S. trial of an oral COVID-19 antiviral therapy that could be prescribed to patients at the first sign of infec...

Latent Tuberculosis Infection (LTBI) Tes...	03/23/21
ReportsnReports.com the exclusive leading provider of market research reports published research report on ???Global Latent Tuberculosis Infection (LT...

Better Buy: Rogers/Shaw or Air Canada/Ai...	03/23/21
Wondering which big acquisition play to focus on right now? Here's my take on two of the biggest recent M&A deals in Canada. The post Better Buy: Roge...

Rizatriptan Benzoate Market Trends and G...	03/23/21
The global Rizatriptan Benzoate market size is projected to grow in the historic period resulted from economic growth in emerging markets, the rise in...

Regeneron, Roche's antibody cocktail cut...	03/23/21
A combination monoclonal antibody cocktail produced by Regeneron and Roche has shown to reduce hospitalization or death in COVID-19 patients by as muc...

Roche/Regeneron Antibody Cocktail Reduce...	03/23/21
No summary available.

Rogers promises better rural internet, c...	03/22/21
Rogers announced it will create a $1 billion fund for rural connectivity if the government allows it to buy Shaw. An advocate warns what it could mean...

CENGN Partners with Rogers to Bring High...	03/22/21
CENGN announces an innovative project that will bring a high-performance 5G wireless distribution network to the Holland Marsh area of Ontario.

SemaThera Enters into a Research Collabo...	03/22/21
MONTREAL--(BUSINESS WIRE)-- #DME--SemaThera enters into a Research Collaboration and Exclusive License Agreement with Roche

Shaw gets a boost with this week???s $26...	03/22/21
Stock surges and setbacks for the week ending March 19, 2021

ANALYST RATINGS

1 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	02/10/21
B. Riley FBR maintains Buy rating and raises Price Target from $200.00 to $215.00

EARNINGS

Date	2021-02-18 (AMC)	Est. (EPS/Rev.)	$1.42/ 203.53M
Actual (EPS/Rev.)	$1.58/ $210.67 M	EPS (TTM)	0

TRADERS TRACKING $ROG

No traders tracking are currently recommending this stock

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.